AstraZeneca Plc Receives Key Lung Cancer Drug Approval In China
March 25, 2017 at 12:58 PM EDT
AstraZeneca plc disclosed Friday via its official WeChat account that a key lung cancer drug has received approval from Chinese regulators, opening up a potentially very lucrative new market in a country where millions suffer from the disease.
